kauliv
strides pharma (cyprus) limited - teriparatida - osteoporosis; osteoporosis, postmenopausal - homeostasis del calcio - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.
forsteo
eli lilly nederland b.v. - teriparatida - osteoporosis; osteoporosis, postmenopausal - homeostasis del calcio - tratamiento de la osteoporosis en mujeres posmenopáusicas y en hombres con mayor riesgo de fractura. en mujeres posmenopáusicas, se ha demostrado una reducción significativa en la incidencia de fracturas vertebrales y no vertebrales, pero no fracturas de cadera. el tratamiento de la osteoporosis asociada con sostenido sistémica de glucocorticoides terapia en las mujeres y los hombres en mayor riesgo de fractura.
fraxiparina 2850 ui 50 xeringues precarregades 0,3 ml
fraxiparina 3800 ui 50 xeringues precarregades 0,4ml
fraxiparina 5700 ui 50 xeringues precarregades 0,6ml
fraxiparina 2.850 ui 10 xeringues 0.3 ml
fraxiparina 7.600 ui 10 xeringues 0.8 ml
fraxiparina forte 11.400 ui 10 xeringues 0.6 ml
fraxiparina forte 15.200 ui 10 xeringues 0.8 ml
fraxiparina forte 19.000 ui 10 xeringues 1 ml